{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T23:12:24Z","timestamp":1777417944537,"version":"3.51.4"},"reference-count":22,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T00:00:00Z","timestamp":1217548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1016\/j.bbrc.2008.05.069","type":"journal-article","created":{"date-parts":[[2008,5,28]],"date-time":"2008-05-28T16:53:29Z","timestamp":1211993609000},"page":"571-577","source":"Crossref","is-referenced-by-count":25,"title":["Elucidation of the role of COX-2 in liver fibrogenesis using transgenic mice"],"prefix":"10.1016","volume":"372","author":[{"given":"Jun","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chung W.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eagle S.H.","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex Y.","family":"Hui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfred S.L.","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minnie Y.Y.","family":"Go","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arthur K.K.","family":"Ching","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiu L.","family":"Chui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henry L.Y.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph J.Y.","family":"Sung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2008.05.069_bib1","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1046\/j.1440-1746.2002.02836.x","article-title":"Cyclooxygenase-2 mRNA is up-regulated in cirrhotic or chronic hepatitis liver adjacent to hepatocellular carcinoma","volume":"17","author":"Morinaga","year":"2002","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbrc.2008.05.069_bib2","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1046\/j.1365-2036.2002.01163.x","article-title":"Expression of cyclooxygenase-2 in chronic hepatitis B and the effects of anti-viral therapy","volume":"16","author":"Cheng","year":"2002","journal-title":"Aliment Pharmacol. Ther."},{"key":"10.1016\/j.bbrc.2008.05.069_bib3","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1038\/modpathol.3800196","article-title":"Expression of HBx and COX-2 in chronic hepatitis B, cirrhosis and hepatocellular carcinoma: implication of HBx in upregulation of COX-2","volume":"17","author":"Cheng","year":"2004","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.bbrc.2008.05.069_bib4","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/hep.20994","article-title":"Troglitazone inhibits tumor growth in hepatocellular carcinoma in vitro and in vivo","volume":"43","author":"Yu","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.bbrc.2008.05.069_bib5","doi-asserted-by":"crossref","first-page":"7908","DOI":"10.1038\/sj.onc.1203286","article-title":"The role of cyclooxygenases in inflammation, cancer, and development","volume":"18","author":"Williams","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.bbrc.2008.05.069_bib6","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1002\/hep.21108","article-title":"COX-2 induction in mice with experimental nutritional steatohepatitis: role as pro-inflammatory mediator","volume":"43","author":"Yu","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.bbrc.2008.05.069_bib7","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1053\/bega.2002.0333","article-title":"Pathogenesis of steatohepatitis","volume":"16","author":"Day","year":"2002","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"10.1016\/j.bbrc.2008.05.069_bib8","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/hep.20280","article-title":"Beyond insulin resistance in NASH: TNF-alpha or adiponectin?","volume":"40","author":"Hui","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.bbrc.2008.05.069_bib9","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/0016-5085(88)90183-7","article-title":"Alcohol-like liver disease in nonalcoholics. A clinical and histologic comparison with alcohol-induced liver injury","volume":"95","author":"Diehl","year":"1988","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbrc.2008.05.069_bib10","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1054\/bjoc.2001.1943","article-title":"Chronic immune activation and inflammation as the cause of malignancy","volume":"85","author":"O\u2019Byrne","year":"2001","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbrc.2008.05.069_bib11","doi-asserted-by":"crossref","first-page":"12013","DOI":"10.1073\/pnas.91.25.12013","article-title":"Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain","volume":"91","author":"Seibert","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbrc.2008.05.069_bib12","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1136\/gut.2006.097923","article-title":"Expression of a COX-2 transgene in murine liver causes hepatitis","volume":"56","author":"Yu","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.bbrc.2008.05.069_bib13","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1478-3231.2005.01202.x","article-title":"Effect of celecoxib on experimental liver fibrosis in rat","volume":"26","author":"Hui","year":"2006","journal-title":"Liver Int."},{"key":"10.1016\/j.bbrc.2008.05.069_bib14","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1021\/tx0155505","article-title":"A protective role for cyclooxygenase-2 in drug-induced liver injury in mice","volume":"4","author":"Reilly","year":"2001","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.bbrc.2008.05.069_bib15","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S0016-5085(03)00904-1","article-title":"JTE-522, a cyclooxygenase-2 inhibitor, is an effective chemopreventive agent against rat experimental liver fibrosis1","volume":"125","author":"Yamamoto","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbrc.2008.05.069_bib16","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1093\/carcin\/18.10.1921","article-title":"Inhibition by piroxicam of oxidative DNA damage, liver cirrhosis and development of enzyme-altered nodules caused by a choline-deficient, l-amino acid-defined diet in rats","volume":"18","author":"Denda","year":"1997","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bbrc.2008.05.069_bib17","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1053\/gast.2001.25480","article-title":"Angiotensin-converting enzyme inhibition attenuates the progression of rat hepatic fibrosis","volume":"121","author":"Jonsson","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbrc.2008.05.069_bib18","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/S0006-291X(02)02301-X","article-title":"Inhibition of the expression of alpha-smooth muscle actin in human hepatic stellate cell line, LI90, by a selective cyclooxygenase 2 inhibitor, NS-398","volume":"297","author":"Cheng","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2008.05.069_bib19","doi-asserted-by":"crossref","first-page":"C259","DOI":"10.1152\/ajpcell.00030.2006","article-title":"Cyclooxygenase-2 is required for activated pancreatic stellate cells to respond to pro-inflammatory cytokines","volume":"292","author":"Aoki","year":"2007","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.bbrc.2008.05.069_bib20","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S0016-5085(03)00904-1","article-title":"JTE-522, a cyclooxygenase-2 inhibitor, is an effective chemopreventive agent against rat experimental liver fibrosis1","volume":"125","author":"Yamamoto","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbrc.2008.05.069_bib21","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1096\/fj.04-2753fje","article-title":"The selective cyclooxygenase-2 inhibitor SC-236 reduces liver fibrosis by mechanisms involving non-parenchymal cell apoptosis and PPARgamma activation","volume":"19","author":"Planaguma","year":"2005","journal-title":"FASEB J."},{"key":"10.1016\/j.bbrc.2008.05.069_bib22","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1124\/jpet.107.128264","article-title":"Comparative protection against liver inflammation and fibrosis by a selective cyclooxygenase-2 inhibitor and a nonredox-type 5-lipoxygenase inhibitor","volume":"323","author":"Horrillo","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X08009765?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X08009765?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,11]],"date-time":"2019-05-11T18:05:44Z","timestamp":1557597944000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X08009765"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["S0006291X08009765"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2008.05.069","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,8]]}}}